CSL SEQIRUS EXPANDS U.S. AVAILABILITY OF INFLUENZA VACCINE FOLLOWING SUCCESSFUL COMPLETION OF THE 2026/27 MANUFACTURING CAMPAIGN

Reuters · 2d ago

Please log in to view news